Genis raises $17M in a recent funding round (Northstack)

December 19, 2022

Originally published by Northstack on 19 December

Genis, the Icelandic biotechnology company, recently issued additional shares for $17M. Numerous investors, including Andri Sveinsson, Sigþór Sigmarsson, and Sigurgeir Guðlaugsson, the CEO of Genis will now be joining the shareholder group. The Icelandic insurance company TM Tryggingar and Yanu Holdings, a global investment firm, also took part in the round.

For the full version of this article, visit Northstack.